This expanded agreement will continue to offer MedAssets’s customers ICU’s products which provide better patient outcomes and cost reduction as well as cost avoidance, said ICU Medical.
Under the terms of the amended agreement, MedAssets will continue to co-market ICU Medical’s Clave and MicroClave Needleless IV systems along with specialty custom sets for a minimum of three additional years, through September 31, 2011.
The two companies will also collaborate on customized programs designed to bring significant value to MedAssets customers.
Rich Costello, vice president of sales at ICU Medical, said: “We look forward to continuing to grow our relationship with MedAssets and believe this expanded agreement will create additional opportunities for growth and validates the growing need for our products throughout the MedAssets customer base.”